Erratum: Protein kinase CKIIa interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells (Oncogene (2003) 22 (8255-8262) DOI: 10.1038/sj.onc.1207156);Protein kinase CKIIα interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells

Oncogene

Volumn 22, Issue 51, 2003, Pages 8255-8262

  Mishra, Suparna ^a,b   Reichert, Anja ^a,b,c   Cunnick, Jess ^a,b   Senadheera, Dinithi ^a,b   Hemmeryckx, Bianca ^a,b   Heisterkamp, Nora ^a,b   Groffen, John ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MTM Laboratories AG   (Germany)

Author keywords

Acute lymphblastic leukemia; Bcr; Bcr Abl P190; CkII ; TBB

Indexed keywords

4,5,6,7 TETRABROMO 2 BENZOTRIAZOLE; BCR ABL PROTEIN; BENZOTRIAZOLE DERIVATIVE; CASEIN KINASE II; CASEIN KINASE II ALPHA; IMATINIB; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; ENZYME INHIBITOR; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; LEUKEMOGENESIS; LYMPHOMA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; TRANSGENIC MOUSE; ANIMAL; CELL DIVISION; CHO CELL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EXON; HAMSTER; METABOLISM; MOUSE; PHYSIOLOGY; TWO HYBRID SYSTEM;

ANIMALIA; MURINAE; MUS MUSCULUS;

ANIMALS; CASEIN KINASE II; CELL DIVISION; CHO CELLS; CRICETINAE; ENZYME INHIBITORS; EXONS; FUSION PROTEINS, BCR-ABL; MICE; MICE, TRANSGENIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0344441923     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207743     Document Type: Erratum

References (46)

1. Battistutta R, De Moliner E, Sarno S, Zanotti G and Pinna LA. (2001). Protein Sci., 10, 2200-2206.
2. Braselmann S and McCormick F. (1995). EMBO J., 14, 4839-4848.
3. Cortez D, Kadlee L and Pendergast AM. (1995). Mol. Cell. Biol., 15, 5531-5541.
4. Deininger MW, O'Brien SG, Ford JM and Druker BJ. (2003). J. Clin. Oncol., 21, 1637-1647.
5. de Langhe S, Haataja L, Senadheera D, Groffen J and Heisterkamp N. (2002). Int. J. Mol. Med., 9, 451-459.
6. Donella-Deana A, Cesaro L, Sarno S, Ruzzene M, Brunati AM, Marin O, Vilk G, Doherty-Kirby A, Lajoie G, Litchfield DW and Pinna LA. (2003). Biochem. J., 372, 841-849.
7. Faust M and Montenarh M. (2000). Cell Tissue Res., 3, 329-340.
8. Fioretos T, Voncken JW, Baram TZ, Kamme F, Groffen J and Heisterkamp N. (1995). Cell. Mol. Biol. Res., 41, 97-102.
9. Ghaffari S, Daley GQ and Lodish HF. (1999). Leukemia, 13, 1200-1206.
10. Guerra B and Issinger OG. (1999). Electrophoresis, 20, 391-408.
11. Guerra B, Siemer S, Boldyreff B and Issinger OG. (1999). FEBS Lett., 462, 353-357.
12. Haataja L, Groffen J and Heisterkamp N. (1998). Int. J. Mol. Med., 1, 665-670.
13. Hawk N, Sun T, Xie S, Wang Y, Wu Y, Liu J and Arlinghaus RB. (2002). Cancer Res., 62, 386-390.
14. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK and Groffen J. (1990). Nature, 344, 251-253.
15. Heisterkamp N and Groffen J. (2001). Chronic Myeloid Leukemia. Biology and Treatment, Carella AM, Daley GQ, Eaves CJ, Goldman JM and Hehlmann R (eds). Martin Dunitz Ltd., London, UK. pp. 3-17.
16. Heriche JK and Chambaz EM. (1998). Oncogene, 17, 13-18.
17. Kaartinen V, Gonzalez-Gomez I, Voncken JW, Faure E, Haataja L, Groffen J and Heisterkamp N. (2001). Development, 128, 4217-4227.
18. Kelliher MA, Seldin DC and Leder P. (1996). EMBO J., 15, 5160-5166.
19. Klucher KM, Lopez DV and Daley GQ. (1998). Blood, 91, 3927-3934.
20. Landesman-Bollag E, Channavajhala PL, Cardiff RD and Seldin DC. (1998). Oncogene, 16, 2965-2974.
21. Laurent E, Talpaz M, Kantarjian H and Kurzrock R. (2001). Cancer Res., 61, 2343-2355.
22. Lebrin F, Chambaz EM and Bianchini L. (2001). Oncogene, 20, 2010-2022.
23. Ling X, Ma G, Sun T, Liu J and Arlinghaus RB. (2003). Cancer Res., 63, 298-303.
24. Litchfield DW. (2003). Biochem. J., 369, 1-15.
25. Ma G, Lu D, Wu Y, Liu J and Arlinghaus RB. (1997). Oncogene, 14, 2367-2372.
26. McWhirter JR, Galasso DL and Wang JY. (1993). Mol. Cell. Biol., 13, 7587-7595.
27. Orlandini M, Semplici F, Ferruzzi R, Meggio F, Pinna LA and Oliviero S. (1998). J. Biol. Chem., 273, 21291-21297.
28. Pendergast AM, Muller AJ, Havlik MH, Maru Y and Witte ON. (1991). Cell, 66, 161-171.
29. Pinna LA. (2003). Acc. Chem. Res., 36, 378-384.
30. Reuther GW, Fu H, Cripe LD, Collier RJ and Pendergast AM. (1994). Science, 266, 129-133.
31. Rifkin IR, Channavajhala PL, Kiefer HL, Carmack AJ, Landesman-Bollag E, Beaudette BC, Jersky B, Salant DJ, Ju ST, Marshak-Rothstein A and Seldin DC. (1998). J. Immunol., 161, 5164-5170.
32. Ruzzene M, Penzo D and Pinna LA. (2002). Biochem. J., 364, 41-47.
33. Rudert F, Visser E, Gradl G, Grandison P, Shemshedini L, Wang S, Grierson A and Watson J. (1996). Gene, 169, 281-282.
34. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA and Cantley LC. (1994). Mol. Cell. Biol., 14, 2777-2785.
35. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A, Shugar D and Pinna LA. (2001). FEBS Lett., 496, 44-48.
36. Sarno S, Moro S, Meggio F, Zagotto G, Dal Ben D, Ghisellini P, Battistutta R, Zanotti G and Pinna LA. (2002). Pharmacol. Ther., 93, 159-168.
37. Seldin DC and Leder P. (1995). Science, 267, 894-897.
38. Takeda N, Shibuya M and Maru Y. (1999). Proc. Natl. Acad. Sci. USA, 96, 203-207.
39. Senadheera D, Haataja L, Groffen J and Heisterkamp N. (2001). Int. J. Mol. Med, 8, 127-133.
40. Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N and Groffen J. (1992a). Cancer Res., 52, 4534-4539.
41. Voncken JW, Morris C, Pattengale P, Dennert G, Kikly C, Groffen J and Heisterkamp N. (1992b). Blood, 79, 1029-1036.
42. Wang D, Westerheide SD, Hanson JL and Baldwin AS. (2000). J. Biol. Chem., 275, 32592-32597.
43. Wang Y, Liu J, Wu Y, Luo W, Lin SH, Lin H, Hawk N, Sun T, Guo JQ, Estrov Z, Talpaz M, Champlin R and Arlinghaus RB. (2001). Cancer Res., 61, 138-144.
44. Xu X, Landesman-Bollag E, Channavajhala PL and Seldin DC. (1999a). Mol. Cell Biochem., 191, 65-74.
45. Xu X, Toselli PA, Russell LD and Seldin DC. (1999b). Nat. Genet., 23, 118-121.
46. Zhao X, Ghaffari S, Lodish H, Malashkevich VN and Kim PS. (2002). Nat. Struct. Biol., 1, 117-200.